Sort   by:  
 Page size 
UnknownThe diagnostic accuracy of lung ultrasound to determine PiCCO-derived extravascular lung water in invasively ventilated patients with COVID-19 ARDS.
Not available
S-EPMC10545605 | biostudies-literature
UnknownLung ultrasound and computed tomography to monitor COVID-19 pneumonia in critically ill patients: a two-center prospective cohort study.
Not available
S-EPMC7829056 | biostudies-literature
UnknownIncidence of transfusion-related acute lung injury temporally associated with solvent/detergent plasma use in the ICU: A retrospective before and after implementation study.
Not available
S-EPMC9544437 | biostudies-literature
UnknownEffect of Low-Normal vs High-Normal Oxygenation Targets on Organ Dysfunction in Critically Ill Patients: A Randomized Clinical Trial.
Not available
S-EPMC8408761 | biostudies-literature
UnknownA Lower Global Lung Ultrasound Score Is Associated with Higher Likelihood of Successful Extubation in Invasively Ventilated COVID-19 Patients.
Not available
S-EPMC8641363 | biostudies-literature
UnknownAnti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
Not available
S-EPMC9451499 | biostudies-literature
UnknownRegional comparison of efficacy and safety for vilobelimab in critically ill, invasively mechanically ventilated COVID-19 patients.
Not available
S-EPMC12010313 | biostudies-literature
UnknownHeterogeneity of treatment effect of vilobelimab in COVID-19: a secondary analysis of a randomised controlled trial.
Not available
S-EPMC11214248 | biostudies-literature
UnknownAssociation between early cumulative fluid balance and successful liberation from invasive ventilation in COVID-19 ARDS patients - insights from the PRoVENT-COVID study: a national, multicenter, observational cohort analysis.
Not available
S-EPMC9157033 | biostudies-literature
UnknownAnti-C5a antibody vilobelimab treatment and the effect on biomarkers of inflammation and coagulation in patients with severe COVID-19: a substudy of the  phase 2 PANAMO trial.
Not available
S-EPMC9789513 | biostudies-literature
Sort   by:  
 Page size